Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Retreat Late Afternoon

Sector Update: Healthcare Stocks Retreat Late Afternoon

MT newswireMT newswire2026/11/19 19:51
03:51 PM EST, 11/19/2026 (MT Newswires) -- Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 2.1% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 2%. The iShares Biotechnology ETF (IBB) shed 0.7%. In corporate news, NeOnc Technologies (NTHI) said the US Food and Drug Administration rescheduled its end-of-phase 1 type B meeting for oral cancer drug NEO212 to Monday from Nov. 17. The meeting's scheduling "does not establish FDA agreement on a trial design or eventual approval of NEO212," the company said Thursday in a statement. Its shares fell nearly 20%. Sanofi (SNY) is mulling an acquisition of US drugmaker Insmed (INSM), Bloomberg reported. Sanofi shares fell 2.4%, and Insmed jumped over 20%. Johnson & Johnson (JNJ) said Thursday that the Memorial Hermann-Texas Medical Center in Houston, Texas, will be the first hospital to install the company's Ottava Robotic Surgical System as part of its early access commercial program. Johnson & Johnson shares were down 2.4%. Halozyme Therapeutics (HALO) said Thursday a German appeals court lifted a preliminary injunction that barred Merck (MRK) from offering or distributing Keytruda SC in Germany. The company will immediately sue Merck for patent infringement in Germany and seek a permanent injunction, Chief Legal Officer Mark Snyder said. Halozyme shares fell 2.9%, and Merck was down 3.8%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!